InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Hagen Heidi, Director. Insider active across 2 companies, notably Vericel Corp. Cumulatively, 5 reports have been logged. Total volume traded: €70k. The latest transaction was filed on 2 September 2021 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations5 total
2,600 shares
Common Stock
SEC:0001593968-22-000888:0·
€35,22523,770 shares@ €1.4819100.0% of flow
Common Stock
SEC:0001209191-21-054829·
Ideal exit: 30 May 2022 (T+270)
€35,22523,770 shares@ €1.481950.0% of flow
Common Stock
SEC:0001209191-21-054829:0·
Ideal exit: 30 May 2022 (T+270)
€7,3941,500 shares@ €4.9290.0004% mcap100.0% of flow
Common Stock
SEC:0001593968-21-001389·
€7,3941,500 shares@ €4.9290.0004% mcap50.0% of flow
Common Stock
SEC:0001593968-21-001389:0·
5 of 5 declarations
About Hagen Heidi
Heidi Hagen is a Board Member at Vericel Corp and ZIOPHARM ONCOLOGY INC. She plays an important role in the governance of these companies, bringing her expertise in strategy and management. As a board member, she participates in strategic decision-making and guides the companies toward a sustainable future.
